EBM — Eastwood Bio-Medical Canada Income Statement
0.000.00%
Last trade - 00:00
- CA$53.04m
- CA$53.08m
- CA$0.87m
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.29 | 0.718 | 0.981 | 1.3 | 0.868 |
Cost of Revenue | |||||
Gross Profit | 0.565 | 0.213 | 0.458 | 0.903 | 0.548 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1.89 | 1.57 | 1.58 | 1.45 | 1.41 |
Operating Profit | -0.596 | -0.854 | -0.604 | -0.15 | -0.547 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.577 | -0.852 | -0.604 | -0.15 | -0.547 |
Net Income After Taxes | -0.577 | -0.852 | -0.604 | -0.15 | -0.547 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.577 | -0.852 | -0.604 | -0.15 | -0.547 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.577 | -0.852 | -0.604 | -0.15 | -0.547 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.008 | -0.014 | -0.009 | -0.002 | -0.008 |